Frontotemporal lobar degeneration: current perspectives

References

• PickAÜber die Beziehungen der senilen Hirnatrophie zur Aphasie. [About the relations of senile brain atrophie and aphasia]Prager Med Wochenschr18921716165167 German
   Google Scholar
• DavatzikosCResnickSMWuXParmpiPClarkCMIndividual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRINeuroimage20084141220122718474436
   PubMed Web of Science ®Google Scholar
• HornbergerMSavageSHsiehSMioshiEPiguetOHodgesJROrbitofrontal dysfunction discriminates behavioral variant frontotemporal dementia from Alzheimer’s diseaseDement Geriatr Cogn Disord201030654755221252550
   PubMed Web of Science ®Google Scholar
• SeeleyWWCrawfordRRascovskyKFrontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementiaArch Neurol200865224925518268196
   PubMedGoogle Scholar
• McKhannGMAlbertMSGrossmanMMillerBDicksonDTrojanowskiJQWork Group on Frontotemporal Dementia and Pick’s DiseaseClinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s DiseaseArch Neurol200158111803180911708987
   PubMed Web of Science ®Google Scholar
• NearyDSnowdenJSGustafsonLFrontotemporal lobar degeneration: a consensus on clinical diagnostic criteriaNeurology1998516154615549855500
   PubMed Web of Science ®Google Scholar
• RascovskyKHodgesJRKnopmanDSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain2011134Pt 92456247721810890
   PubMed Web of Science ®Google Scholar
• [No authors listed]Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester GroupsJ Neurol Neurosurg Psychiatry19945744164188163988
   PubMed Web of Science ®Google Scholar
• RascovskyKGrossmanMClinical diagnostic criteria and classification controversies in frontotemporal lobar degenerationInt Rev Psychiatry201325214515823611345
   PubMed Web of Science ®Google Scholar
• Shamay-TsoorySGThe neural bases for empathyNeuroscientist2011171182421071616
   PubMed Web of Science ®Google Scholar
• AdenzatoMCavalloMEnriciITheory of mind ability in the behavioural variant of frontotemporal dementia: an analysis of the neural, cognitive, and social levelsNeuropsychologia201048121219666039
   PubMed Web of Science ®Google Scholar
• HueyEDArmstrongNMomeniPGrafmanJChallenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementiaExpert Opin Ther Targets200812111367137618851693
   PubMed Web of Science ®Google Scholar
• IkedaMBrownJHollandAJFukuharaRHodgesJRChanges in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s diseaseJ Neurol Neurosurg Psychiatry200273437137612235302
   PubMed Web of Science ®Google Scholar
• PiguetOPetersénAYin Ka LamBEating and hypothalamus changes in behavioral-variant frontotemporal dementiaAnn Neurol201169231231921387376
   PubMed Web of Science ®Google Scholar
• DaviesRRScahillVLGrahamAWilliamsGBGrahamKSHodgesJRDevelopment of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometryNeuroradiology200951849150319308367
   PubMed Web of Science ®Google Scholar
• Gorno-TempiniMLHillisAEWeintraubSClassification of primary progressive aphasia and its variantsNeurology201176111006101421325651
   PubMed Web of Science ®Google Scholar
• BrambatiSMRankinKPNarvidJAtrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry studyNeurobiol Aging200930110311117604879
   PubMed Web of Science ®Google Scholar
• RohrerJDWarrenJDModatMPatterns of cortical thinning in the language variants of frontotemporal lobar degenerationNeurology200972181562156919414722
   PubMed Web of Science ®Google Scholar
• BozeatSGregoryCARalphMAHodgesJRWhich neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease?J Neurol Neurosurg Psychiatry200069217818610896690
   PubMed Web of Science ®Google Scholar
• SeeleyWWBauerAMMillerBLThe natural history of temporal variant frontotemporal dementiaNeurology20056481384139015851728
   PubMed Web of Science ®Google Scholar
• JosephsKAWhitwellJLKnopmanDSTwo distinct subtypes of right temporal variant frontotemporal dementiaNeurology200973181443145019884571
   PubMed Web of Science ®Google Scholar
• GrossmanMAshSPrimary progressive aphasia: a reviewNeurocase200410131815849155
   PubMed Web of Science ®Google Scholar
• HarrisJMGallCThompsonJCClassification and pathology of primary progressive aphasiaNeurology201381211832183924142474
   PubMed Web of Science ®Google Scholar
• Sixel-DöringFSchweitzerMMollenhauerBTrenkwalderCPolysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsySleep Med200910440741518945638
   PubMed Web of Science ®Google Scholar
• BakTHHodgesJRCorticobasal degeneration: clinical aspectsHandb Clin Neurol20088950952118631773
   PubMedGoogle Scholar
• BrunsMBJosephsKANeuropsychiatry of corticobasal degeneration and progressive supranuclear palsyInt Rev Psychiatry201325219720923611349
   PubMed Web of Science ®Google Scholar
• KerteszAMcMonaglePBlairMDavidsonWMunozDGThe evolution and pathology of frontotemporal dementiaBrain2005128Pt 91996200516033782
   PubMed Web of Science ®Google Scholar
• Lomen-HoerthCMurphyJLangmoreSKramerJHOlneyRKMillerBAre amyotrophic lateral sclerosis patients cognitively normal?Neurology20036071094109712682312
   PubMed Web of Science ®Google Scholar
• MurphyJMHenryRGLangmoreSKramerJHMillerBLLomen-HoerthCContinuum of frontal lobe impairment in amyotrophic lateral sclerosisArch Neurol200764453053417420314
   PubMedGoogle Scholar
• RossoSMDonker KaatLBaksTFrontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based studyBrain2003126Pt 92016202212876142
   PubMed Web of Science ®Google Scholar
• RatnavalliEBrayneCDawsonKHodgesJRThe prevalence of frontotemporal dementiaNeurology200258111615162112058088
   PubMed Web of Science ®Google Scholar
• JohnsonJKDiehlJMendezMFFrontotemporal lobar degeneration: demographic characteristics of 353 patientsArch Neurol200562692593015956163
   PubMedGoogle Scholar
• MackenzieIRAFotiDWoulfeJHurwitzTAAtypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusionsBrain2008131Pt 51282129318362096
   PubMed Web of Science ®Google Scholar
• HodgesJRDaviesRXuerebJKrilJHallidayGSurvival in frontotemporal dementiaNeurology200361334935412913196
   PubMed Web of Science ®Google Scholar
• NunnemannSLastDSchusterTFörstlHKurzADiehl-SchmidJSurvival in a German population with frontotemporal lobar degenerationNeuroepidemiology2011373–416016522056939
   PubMed Web of Science ®Google Scholar
• Diehl-SchmidJPohlCPerneczkyRHartmannJFörstlHKurzAFrühsymptome, Überlebenszeit und Todesursachen - Beobachtungen an 115 Patienten mit Demenz auf der Grundlage frontotemporaler lobärer Degenerationen. [Initial symptoms, survival and causes of death in 115 patients with frontotemporal lobar degeneration]Fortschr Neurol Psychiatr20077512708713 German16972211
   PubMed Web of Science ®Google Scholar
• PijnenburgYALGillissenFJonkerCScheltensPInitial complaints in frontotemporal lobar degenerationDement Geriatr Cogn Disord200417430230615178941
   PubMed Web of Science ®Google Scholar
• KerteszADavidsonWFoxHFrontal behavioral inventory: diagnostic criteria for frontal lobe dementiaCan J Neurol Sci199724129369043744
   PubMed Web of Science ®Google Scholar
• GraceJMalloyPFrontal Systems Behavior Scale: Professional ManualLutz, FLPAR Inc2001 [cited September 7, 2013]. Available from: http://www4.parinc.com/Products/Product.aspx?ProductID=FRSBE
   Google Scholar
• SchroeterMLRaczkaKNeumannJYves von CramonDTowards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjectsNeuroimage200736349751017478101
   PubMed Web of Science ®Google Scholar
• SchroeterMLRaczkaKNeumannJvon CramonDYNeural networks in frontotemporal dementia – a meta-analysisNeurobiol Aging200829341842617140704
   PubMed Web of Science ®Google Scholar
• KippsCMDaviesRRMitchellJKrilJJHallidayGMHodgesJRClinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scaleDement Geriatr Cogn Disord200723533434217374952
   PubMed Web of Science ®Google Scholar
• BarnesJWhitwellJLFrostCJosephsKARossorMFoxNCMeasurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degenerationArch Neurol200663101434143917030660
   PubMedGoogle Scholar
• JosephsKADicksonDWHippocampal sclerosis in tau-negative frontotemporal lobar degenerationNeurobiol Aging200728111718172216930776
   PubMed Web of Science ®Google Scholar
• LindbergOWalterfangMLooiJCHippocampal shape analysis in Alzheimer’s disease and frontotemporal lobar degeneration subtypesJ Alzheimers Dis201230235536522414571
   PubMed Web of Science ®Google Scholar
• Gorno-TempiniMLDronkersNFRankinKPCognition and anatomy in three variants of primary progressive aphasiaAnn Neurol200455333534614991811
   PubMed Web of Science ®Google Scholar
• JosephsKADuffyJRStrandEAClinicopathological and imaging correlates of progressive aphasia and apraxia of speechBrain2006129Pt 61385139816613895
   PubMed Web of Science ®Google Scholar
• RogalskiECobiaDHarrisonTMWienekeCWeintraubSMesulamM-MProgression of language decline and cortical atrophy in subtypes of primary progressive aphasiaNeurology201176211804181021606451
   PubMed Web of Science ®Google Scholar
• DrzezgaAGrimmerTHenriksenGImaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s diseaseNeuroimage200839261963317962045
   PubMed Web of Science ®Google Scholar
• RabinoviciGDFurstAJO’NeilJP11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degenerationNeurology200768151205121217420404
   PubMed Web of Science ®Google Scholar
• BiblMMollenhauerBLewczukPCerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasiasDement Geriatr Cogn Disord2011311374421135556
   PubMed Web of Science ®Google Scholar
• HuttonMLendonCLRizzuPAssociation of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature199839366867027059641683
   PubMed Web of Science ®Google Scholar
• RademakersRCrutsMvan BroeckhovenCThe role of tau (MAPT) in frontotemporal dementia and related tauopathiesHum Mutat200424427729515365985
   PubMed Web of Science ®Google Scholar
• BrandtRHundeltMShahaniNTau alteration and neuronal degeneration in tauopathies: mechanisms and modelsBiochim Biophys Acta200517392–333135415615650
   PubMed Web of Science ®Google Scholar
• Le BerIGenetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithmRev Neurol (Paris)20131691081181924011980
   PubMed Web of Science ®Google Scholar
• BakerMMackenzieIRPickering-BrownSMMutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature2006442710591691916862116
   PubMed Web of Science ®Google Scholar
• SiebenAVan LangenhoveTEngelborghsSThe genetics and neuropathology of frontotemporal lobar degenerationActa Neuropathol2012124335337222890575
   PubMed Web of Science ®Google Scholar
• RademakersRBakerMGassJPhenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C – >T (Arg493X) mutation: an international initiativeLancet Neurol200761085786817826340
   PubMed Web of Science ®Google Scholar
• RentonAEMajounieEWaiteAITALSGEN ConsortiumA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDNeuron201172225726821944779
   PubMed Web of Science ®Google Scholar
• van der ZeeJGijselinckIDillenLEuropean Early-Onset Dementia ConsortiumA pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeatsHum Mutat201334236337323111906
   PubMed Web of Science ®Google Scholar
• LoyCTSchofieldPRTurnerAMKwokJBGenetics of dementiaLancet Epub852013
   Web of Science ®Google Scholar
• SnowdenJSRollinsonSThompsonJCDistinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutationsBrain2012135Pt 369370822300873
   PubMed Web of Science ®Google Scholar
• WattsGDWymerJKovachMJInclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNat Genet200436437738115034582
   PubMed Web of Science ®Google Scholar
• SkibinskiGParkinsonNJBrownJMMutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaNat Genet200537880680816041373
   PubMed Web of Science ®Google Scholar
• GoldmanJSHahnSECataniaJWAmerican College of Medical Genetics and the National Society of Genetic CounselorsGenetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsGenet Med201113659760521577118
   PubMed Web of Science ®Google Scholar
• NeumannMTolnayMMackenzieIRAThe molecular basis of frontotemporal dementiaExpert Rev Mol Med200911e2319638255
   PubMed Web of Science ®Google Scholar
• MackenzieIRNeumannMBigioEHNomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an updateActa Neuropathol201011911419924424
   PubMed Web of Science ®Google Scholar
• NeumannMSampathuDMKwongLKUbiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisScience2006314579613013317023659
   PubMed Web of Science ®Google Scholar
• MackenzieIRNeumannMBaborieAA harmonized classification system for FTLD-TDP pathologyActa Neuropathol2011122111111321644037
   PubMed Web of Science ®Google Scholar
• RademakersRNeumannMMackenzieIRAdvances in understanding the molecular basis of frontotemporal dementiaNat Rev Neurol20128842343422732773
   PubMed Web of Science ®Google Scholar
• AshPEABieniekKFGendronTFUnconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALSNeuron201377463964623415312
   PubMed Web of Science ®Google Scholar
• MoriKWengSMArzbergerTThe C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALSScience201333961251335133823393093
   PubMed Web of Science ®Google Scholar
• NeumannMBentmannEDormannDFET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutationsBrain2011134Pt 92595260921856723
   PubMed Web of Science ®Google Scholar
• ProcterAWQurneMFrancisPTNeurochemical features of frontotemporal dementiaDement Geriatr Cogn Disord199910 Suppl 1808410436347
   PubMed Web of Science ®Google Scholar
• HueyEDPutnamKTGrafmanJA systematic review of neurotransmitter deficits and treatments in frontotemporal dementiaNeurology2006661172216401839
   PubMed Web of Science ®Google Scholar
• SjögrenMMinthonLPassantUBlennowKWallinADecreased monoamine metabolites in frontotemporal dementia and Alzheimer’s diseaseNeurobiol Aging19981953793849880039
   PubMed Web of Science ®Google Scholar
• RinneJOLaineMKaasinenVNorvasuo-HeiläMKNågrenKHeleniusHStriatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementiaNeurology200258101489149312034784
   PubMed Web of Science ®Google Scholar
• Diehl-SchmidJLastDSchusterTFörstlHSchneider-SchelteHKurzAHealth care utilization in frontotemporal lobar degenerationAlzheimer Dis Assoc Disord201226216617021705868
   PubMed Web of Science ®Google Scholar
• BeiHuRossLNeuhausJOff-label medication use in frontotemporal dementiaAm J Alzheimers Dis Other Demen201025212813320124256
   PubMed Web of Science ®Google Scholar
• ManoochehriMHueyEDDiagnosis and management of behavioral issues in frontotemporal dementiaCurr Neurol Neurosci Rep201212552853622847063
   PubMed Web of Science ®Google Scholar
• O’BrienJTBurnsABAP Dementia Consensus GroupClinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for PsychopharmacologyJ Psychopharmacol2011258997101921088041
   PubMed Web of Science ®Google Scholar
• FrancoKNMessinger-RapportBPharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidenceJ Am Med Dir Assoc20067320120216503315
   PubMed Web of Science ®Google Scholar
• CurtisRCReschDSCase of pick’s central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidoneJ Clin Psychopharmacol200020338438510831030
   PubMed Web of Science ®Google Scholar
• FellgiebelAMüllerMJHiemkeCBartensteinPSchreckenbergerMClinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolismWorld J Biol Psychiatry20078212312617455105
   PubMed Web of Science ®Google Scholar
• MorettiRTorrePAntonelloRMCazzatoGGriggioSBavaAOlanzapine as a treatment of neuropsychiatric disorders of Alzheimer’s disease and other dementias: a 24-month follow-up of 68 patientsAm J Alzheimers Dis Other Demen200318420521412955785
   PubMedGoogle Scholar
• PijnenburgYALSampsonELHarveyRJFoxNCRossorMNVulnerability to neuroleptic side effects in frontotemporal lobar degenerationInt J Geriatr Psychiatry2003181677212497558
   PubMed Web of Science ®Google Scholar
• GillSSBronskillSENormandSLAntipsychotic drug use and mortality in older adults with dementiaAnn Intern Med20071461177578617548409
   PubMed Web of Science ®Google Scholar
• KortteKBRogalskiEJBehavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasiaInt Rev Psychiatry201325223724523611353
   PubMed Web of Science ®Google Scholar
• HallGRShapiraJGallagherMDennySSManaging differences: care of the person with frontotemporal degenerationJ Gerontol Nurs2013393101423394488
   PubMed Web of Science ®Google Scholar
• MerrileesJA model for management of behavioral symptoms in frontotemporal lobar degenerationAlzheimer Dis Assoc Disord2007214S64S6918090427
   PubMed Web of Science ®Google Scholar
• MerrileesJKetelleRAdvanced practice nursing: meeting the caregiving challenges for families of persons with frontotemporal dementiaClin Nurse Spec201024524525120716977
   PubMed Web of Science ®Google Scholar
• RomeroBWenzMKonzept und Wirksamkeit eines Behandlungsprogrammes für Demenzkranke und deren Angehörige Ergebnisse aus dem Alzheimer Therapiezentrum Bad Aibling. [Concept and effectiveness of a treatment program for patients with dementia and their relatives. Results from the Bad Aibling Alzheimer Disease Therapy Center]Z Gerontol Geriatr2002352118128 German12080575
   PubMed Web of Science ®Google Scholar
• CrootKNickelsLLaurenceFManningMImpairment- and activity/participation-directed interventions in progressive language impairment: Clinical and theoretical issuesAphasiology2009232125160
   Web of Science ®Google Scholar
• JokelRCupitJRochonELeonardCRelearning lost vocabulary in nonfluent progressive aphasia with MossTalk Words®Aphasiology2009232175191
   Web of Science ®Google Scholar
• NewhartMDavisCKannanVHeidler-GaryJCloutmanLHillisAETherapy for naming deficits in two variants of primary progressive aphasiaAphasiology2009237–8823834
   Web of Science ®Google Scholar
• KhayumBWienekeCRogalskiERobinsonJO’HaraMThinking Outside the Stroke: Treating Primary Progressive Aphasia (PPA)Perspect Gerontol20121723749
   PubMedGoogle Scholar
• Boutoleau-BretonnièreCVercellettoMVolteauCRenouPLamyEZarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementiaDement Geriatr Cogn Disord200825327227718285675
   PubMed Web of Science ®Google Scholar
• MioshiEBristowMCookRHodgesJRFactors underlying caregiver stress in frontotemporal dementia and Alzheimer’s diseaseDement Geriatr Cogn Disord2009271768119155621
   PubMed Web of Science ®Google Scholar
• RiedijkSRDe VugtMEDuivenvoordenHJCaregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer’s diseaseDement Geriatr Cogn Disord2006225–640541216966830
   PubMed Web of Science ®Google Scholar
• NunnemannSKurzALeuchtSDiehl-SchmidJCaregivers of patients with frontotemporal lobar degeneration: a review of burden, problems, needs, and interventionsInt Psychogeriatr20122491368138622717212
   PubMed Web of Science ®Google Scholar
• BakkerCde VugtMEvan VlietDUnmet needs and health-related quality of life in young-onset dementiaAm J Geriatr Psychiatry EpubJuly172013
   Web of Science ®Google Scholar
• Diehl-SchmidJSchmidtE-MNunnemannSCaregiver burden and needs in frontotemporal dementiaJ Geriatr Psychiatry Neurol201326422122923904354
   PubMed Web of Science ®Google Scholar
• ShnallAAgateAGrinbergAHuijbregtsMNguyenMQChowTWDevelopment of supportive services for frontotemporal dementias through community engagementInt Rev Psychiatry201325224625223611354
   PubMed Web of Science ®Google Scholar
• TauRx Therapeutics LtdSafety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) Available from: http://clinicaltrials.gov/show/NCT01626378 NLM identifier: NCT01626378Accessed December 9, 2013
   Google Scholar
• VaccaroAPattenSACiuraSMethylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerioPloS One201277e4211722848727
   PubMed Web of Science ®Google Scholar
• BoxerALGoldMHueyEFrontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug developmentAlzheimers Dement20139217618823043900
   PubMed Web of Science ®Google Scholar
• WestatA Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration Available from: http://clinicaltrials.gov/show/NCT00703677 NLM identifier: NCT00703677Accessed December 9, 2013
   Google Scholar
• NosciraSAEfficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer’s Disease Patients (ARGO) Available from: http://clinicaltrials.gov/show/NCT01350362 NLM identifier: NCT01350362Accessed December 9, 2013
   Google Scholar
• NosciraSASafety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy (Tauros) Available from: http://clinicaltrials.gov/show/NCT01049399 NLM identifier: NCT01049399Accessed December 9, 2013
   Google Scholar
• BensimonGLudolphAAgidYVidailhetMPayanCLeighPNNNIPPS Study GroupRiluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyBrain2009132Pt 115617119029129
   PubMed Web of Science ®Google Scholar
• StamelouMReussAPilatusUShort-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trialMov Disord200823794294918464278
   PubMed Web of Science ®Google Scholar
• LorenzlSEfficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy (PROSPERA) Available from: http://clinicaltrials.gov/show/NCT01187888 NLM identifier: NCT01187888Accessed December 9, 2013
   Google Scholar
• Allon TherapeuticsStudy to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy Available from: http://clinicaltrials.gov/show/NCT01110720 NLM identifier: NCT01110720Accessed December 9, 2013
   Google Scholar
• University of California, San FranciscoDavunetide (AL-108) in Predicted Tauopathies – Pilot Study Available from: http://clinicaltrials.gov/show/NCT01056965 NLM identifier: NCT01056965Accessed December 9, 2013
   Google Scholar
• MorettiRTorrePAntonelloRMCattaruzzaTCazzatoGBavaARivastigmine in frontotemporal dementia: an open-label studyDrugs Aging2004211493193715554751
   PubMed Web of Science ®Google Scholar
• MendezMFShapiraJSMcMurtrayALichtEPreliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementiaAm J Geriatr Psychiatry2007151848717194818
   PubMed Web of Science ®Google Scholar
• LamplYSadehMLorberboymMEfficacy of acetylcholinesterase inhibitors in frontotemporal dementiaAnn Pharmacother200438111967196815479775
   PubMed Web of Science ®Google Scholar
• KerteszAMorlogDLightMGalantamine in frontotemporal dementia and primary progressive aphasiaDement Geriatr Cogn Disord200825217818518196898
   PubMed Web of Science ®Google Scholar
• Diehl-SchmidJFörstlHPerneczkyRPohlCKurzAA 6-month, open-label study of memantine in patients with frontotemporal dementiaInt J Geriatr Psychiatry200823775475918213609
   PubMed Web of Science ®Google Scholar
• VercellettoMBoutoleau-BretonnièreCVolteauCFrench research network on Frontotemporal dementiaMemantine in behavioral variant frontotemporal dementia: negative resultsJ Alzheimers Dis201123474975921157021
   PubMed Web of Science ®Google Scholar
• ChowTWGraff-GuerreroAVerhoeffNPOpen-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementiaNeuropsychiatr Dis Treat2011741542421792308
   PubMed Web of Science ®Google Scholar
• BoxerALKnopmanDSKauferDIMemantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trialLancet Neurol201312214915623290598
   PubMed Web of Science ®Google Scholar
• DeakinJBRahmanSNestorPJHodgesJRSahakianBJParoxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trialPsychopharmacology (Berl)2004172440040814666399
   PubMed Web of Science ®Google Scholar
• MendezMFShapiraJSMillerBLStereotypical movements and frontotemporal dementiaMov Disord200520674274515786492
   PubMed Web of Science ®Google Scholar
• LebertFStekkeWHasenbroekxCPasquierFFrontotemporal dementia: a randomised, controlled trial with trazodoneDement Geriatr Cogn Disord200417435535915178953
   PubMed Web of Science ®Google Scholar
• IkedaMShigenobuKFukuharaREfficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patientsDement Geriatr Cogn Disord200417311712114739531
   PubMed Web of Science ®Google Scholar
• HerrmannNBlackSEChowTCappellJTang-WaiDFLanctôtKLSerotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementiaAm J Geriatr Psychiatry201220978979721878805
   PubMed Web of Science ®Google Scholar
• AdlerGTeufelMDrachLMPharmacological treatment of frontotemporal dementia: treatment response to the MAO-A inhibitor moclobemideInt J Geriatr Psychiatry200318765365512833310
   PubMed Web of Science ®Google Scholar
• HueyEDGarciaCWassermannEMTierneyMCGrafmanJStimulant treatment of frontotemporal dementia in 8 patientsJ Clin Psychiatry200869121981198219203481
   PubMed Web of Science ®Google Scholar
• ReedDAJohnsonNAThompsonCWeintraubSMesulamMMA clinical trial of bromocriptine for treatment of primary progressive aphasiaAnn Neurol200456575015505780
   PubMed Web of Science ®Google Scholar
• RahmanSRobbinsTWHodgesJRMethylphenidate (‘Ritalin’) can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementiaNeuropsychopharmacology200631365165816160709
   PubMed Web of Science ®Google Scholar